{
    "title": "Synairgen therapy fails in late-stage study in COVID patients; shares sink",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10534703/Synairgen-therapy-fails-late-stage-study-COVID-patients-shares-sink.html",
    "date": "2022-02-21",
    "keywords": [
        "trial",
        "sng001",
        "aripaka",
        "therapy",
        "covid19",
        "value",
        "protein",
        "interferon",
        "beta",
        "treatment",
        "placebo",
        "top",
        "care",
        "sprinter",
        "pence",
        "stock",
        "monday",
        "blow",
        "development",
        "product",
        "formulation",
        "broadspectrum",
        "stay",
        "drug",
        "change",
        "outcome",
        "standard",
        "phase",
        "richard",
        "marsden",
        "improvement",
        "potential",
        "company",
        "dataset",
        "synairgen",
        "university",
        "southampton",
        "market",
        "share",
        "gmt",
        "virus",
        "production",
        "body",
        "nebuliser",
        "latestage",
        "athome",
        "use",
        "health",
        "part",
        "pushkala",
        "bengaluru",
        "editing",
        "dasgupta",
        "bernadette",
        "baum"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}